文献速递妇科

盆腔重建手术后直肠内给予地西泮:双盲、随机、安慰剂对照试验

Intrarectal diazepam following pelvic reconstructive surgery: a double-blind, randomized placebo-controlled trial.
PubMed 文献 · Am J Obstet Gynecol · 2022-05-10

本研究为双盲随机安慰剂对照试验,比较经阴道子宫切除加自体组织盆腔重建术后直肠内给予10 mg地西泮栓剂与安慰剂的术后疼痛评分。结果显示两组术后早期阴道疼痛评分无差异(25 vs 21 mm,P=.285),安慰剂组在术后2周对住院期间及居家疼痛控制的满意度略高,作者认为术后方案中加用地西泮并无必要。

要点

  • 直肠内10 mg地西泮组与安慰剂组术后3.5至6.0小时阴道疼痛视觉模拟评分无差异(25 vs 21 mm,P=.285)。
  • 两组术后即刻补救麻醉药用量无差异(19.0 vs 17.0 MME,P=.202)。
  • 术后2周安慰剂组对住院期间疼痛控制满意度高于地西泮组(31 vs 43 mm,P=.006)。

核心结论

  • 盆腔重建手术后立即放置10 mg地西泮直肠栓剂未改善术后早期疼痛或麻醉药使用。
  • 尽管安慰剂组在术后2周报告对疼痛控制的满意度略高,但总体疼痛水平较低,作者认为术后方案中加用地西泮并无必要。

研究设计与样本

  • 双盲、随机、安慰剂对照试验,比较经阴道子宫切除加自体组织脱垂修补术后疼痛评分。
  • 患者随机接受直肠内10 mg地西泮栓剂或外观相同的安慰剂。
  • 基于视觉模拟评分10 mm术后阴道疼痛差异,计算样本量为每组55例,以达到80%把握度,α=.05。
  • 2020年2月至2021年8月共随机130例,7例退出,123例纳入分析:地西泮组60例,安慰剂组63例。
  • 中位年龄65岁(四分位距27-80),中位体重指数27.9 kg/m2(四分位距18.70-45.90),123例中119例(96.7%)为白人。

主要发现

  • 主要结局术后3.5至6.0小时阴道疼痛评分两组无差异(25 vs 21 mm;P=.285)。
  • 术后即刻补救麻醉药用量两组无差异(19.0 vs 17.0 MME;P=.202)。
  • 术后2周安慰剂组对住院期间疼痛控制满意度高于地西泮组(31 vs 43 mm;P=.006)。
  • 术后2周安慰剂组对居家疼痛控制满意度高于地西泮组(31 vs 42 mm;P=.022)。
  • 当日出院与留院过夜者之间未观察到差异。

关键数值与推荐

  • 主要结局为术后约3小时基于视觉模拟评分的疼痛评分。
  • 次要结局包括术后总吗啡当量、患者对疼痛控制的满意度、当日出院结局和总体满意度。
  • 123例中50例(41%)放置了中段尿道吊带,61例(50%)于手术当日出院。
  • 大多数参与者同时行子宫骶韧带悬吊加前后壁修补。

临床怎么用

  • 原文结论认为术后方案中加用地西泮并无必要,未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients undergoing vaginal hysterectomy with native tissue pelvic reconstruction typically have low pain levels overall in the postoperative period. Notwithstanding, pain control immediately after surgery may be more challenging and a barrier to same-day discharge. Intrarectal diazepam has been used for acute and chronic pelvic pain and has a pharmacokinetic profile ideal for intermittent use. However, its use has not been investigated after the surgical intervention. OBJECTIVE: This study aimed to evaluate the effect of diazepam rectal suppositories on early postoperative pain after hysterectomy and vaginal reconstruction for pelvic organ prolapse. STUDY DESIGN: This was a double-blind, randomized, placebo-controlled trial comparing postoperative pain scores after vaginal hysterectomy with native tissue prolapse repairs. Patients were randomized to receive either an intrarectal 10-mg diazepam suppository or an identical placebo. Moreover, the participants completed the questionnaires at baseline, the morning of postoperative day 1, and 2 weeks after the operation. Surveys included visual analog scales for pain, a validated Surgical Satisfaction Questionnaire, and queries regarding medication side effects and postoperative recovery. The primary outcome was pain scores based on a visual analog scale approximately 3 hours after surgery. The secondary outcomes included total morphine equivalents after surgery, patient satisfaction with pain control, same-day discharge outcome, and overall satisfaction. The chi-square, Fisher exact, and Mann-Whitney tests were used. Based on a 10-mm difference in postoperative vaginal pain using the visual analog scale, sample size was calculated to be 55 patients in each arm to achieve 80% power with an alpha of.05. RESULTS: From February 2020 to August 2021, 130 participants were randomized. Of those participants, 7 withdrew, and 123 were analyzed: 60 in the diazepam group and 63 in the placebo group. The median age was 65 years (interquartile range, 27-80), the median body mass index was 27.9 kg/m2 (interquartile range, 18.70-45.90), and 119 of 123 participants (96.7%) were White. There was no difference in the baseline characteristics, prolapse stage, or types of procedures performed between groups. Most participants had concurrent uterosacral ligament suspension with anterior and posterior repairs. Of note, 50 of 123 participants (41%) had midurethral slings. Moreover, 61 of 123 participants (50%) were discharged on the day of surgery. There was no difference in the primary outcome of vaginal pain 3.5 to 6.0 hours postoperatively (25 vs 21 mm; P=.285). In addition, the amount of rescue narcotics used in the immediate postoperative period (19.0 vs 17.0 MME; P=.202) did not differ between groups. At 2-weeks postoperatively, patients in the placebo group reported higher satisfaction with pain control in the hospital (31 vs 43 mm; P=.006) and pain control at home (31 vs 42 mm; P=.022). No difference was noted between same-day discharges and those who were admitted overnight. CONCLUSION: The placement of a 10-mg diazepam rectal suppository immediately after pelvic reconstructive surgery did not improve pain or narcotic usage in the early postoperative period. Although the placebo group reported slightly higher satisfaction with pain control 2 weeks after surgery, overall pain levels were low. Therefore, we do not believe that the addition of diazepam to the postoperative regimen is warranted.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Aldrich ER, Tam TY, Saylor LM, et al. Intrarectal diazepam following pelvic reconstructive surgery: a double-blind, randomized placebo-controlled trial. Am J Obstet Gynecol. 2022. PMID: 35550374. doi:10.1016/j.ajog.2022.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。